Veterinary Medicine Information website

Feliserin Plus Injektionslösung für Katzen und Hunde

Authorised
  • HORSE PROTEINS
  • Immunoglobulins against feline panleukopenia virus, Equine
  • Immunoglobulins against Felid herpesvirus 1, Equine
  • Immunoglobulins against feline Calicivirus, strain 255, Equine
  • Immunoglobulins against feline Calicivirus, strain 2024, Equine
Download as PDF

Product identification

Medicine name:
Feliserin Plus Injektionslösung für Katzen und Hunde
Active substance:
  • HORSE PROTEINS
  • Immunoglobulins against feline panleukopenia virus, Equine
  • Immunoglobulins against Felid herpesvirus 1, Equine
  • Immunoglobulins against feline Calicivirus, strain 255, Equine
  • Immunoglobulins against feline Calicivirus, strain 2024, Equine
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • HORSE PROTEINS
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Immunoglobulins against feline panleukopenia virus, Equine
    10000.00
    50% neutralisation dose
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Felid herpesvirus 1, Equine
    100.00
    50% neutralisation dose
    /
    1.00
    millilitre(s)
  • Immunoglobulins against feline Calicivirus, strain 255, Equine
    10000.00
    50% neutralisation dose
    /
    1.00
    millilitre(s)
  • Immunoglobulins against feline Calicivirus, strain 2024, Equine
    10000.00
    50% neutralisation dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AM01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Tiergesundheit GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Tiergesundheit (Riems) GmbH
  • IDT Biologika GmbH
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 35a/92
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 4/09/2025
Download